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f^ eurobehavioral Symptoms in Mild Primary Hyperparathyroidism: 
Related to Hypercalcemia but not Improved by Parathyroidectomy 
Gregory G. Brown, PhD,* Richard C. Preisman, MD,* and Michael Kleerekoper, MD^  
The neurobehavioral symptomatology of severe primary hyperparathyroidism (PHPT) has been 
thoroughly described. Less is known about more mild cases. We evaluated 34 patients with mild PHPT 
and followed 19 for an average of six months. Of those cases followed, ten had parathyroidectomy 
(PTX). Patients with no neurobehavioral abnormalities had the lowest serum calcium levels (10.9 ± 
0.88 mg/dL), patients with signs of affective disorder had intermediate levels (11.25 ± 0.66 mg/dL), 
and patients with signs of cerebral dysfunction had the highest levels (12.17 ± 1.17 mg/dL). Serum 
calcium significantly correlated with motor speed, psychomotor speed, fluid intelligence, and short-
term memory. However, in the follow-up of patients, PTX seemed to have no effect on their behavior 
Serum calcium correlates with both type and severity ofthe neurobehavioral abnormalities found in 
mild PHPT. However, most of the evidence indicates that PTX does not produce any improvement of 
these abnormalities, even when the hypercalcemia elevation is corrected. (Henry Ford Hosp MedJ 
1987:35:211-5) 
neoplasms and I 
parathyroidism 
I 
Avariety of neurobehavioral symptoms have been associated with primary hyperparathyroidism (PHPT) since Nielsen 
drew attention to this phenomenon in the mid 1930s and early 
1940s (1,2). Lethargy, drowsiness, depressive mood, neuras-
thenia, paranoid delusions, hallucinations, disorientation, con-
fusion, and memory deficits all have been reported in a series 
of case studies (3-8). However, group studies have not always 
found a greater occunence of psychiatric symptoms in PHPT 
than would be expected among medically i l l patients in gen-
eral (9-20). As shown in the Table, prevalence rates from case-
series studies range from 1% to 65%. The validity of many of 
these rates is difficult to evaluate, since most investigators ob-
tained data through retrospective chart review, did not state how 
patients were sampled, or failed to describe the method used to 
investigate the presence of psychiatric symptoms. Only two 
studies (12,20) reported their methods in sufficient detail to en-
able us to determine that a consecutive series was examined, and 
only three studies (17,18,20) described their method of psychi-
atric evaluation. 
With the advent of routine biochemical screening, a dramatic 
increase has occuned in the detection of cases of hypercalcemia 
with few or no other symptoms of PHPT (21). Many patients 
presenting with mild hypercalcemia have neurobehavioral com-
plaints as their only symptoms. Whether surgical conection of 
PHPT is indicated in these patients is a question that the afore-
mentioned literature does not convincingly answer Several 
authors have claimed that mental changes may occur at mild 
calcium elevations and clear with parathyroidectomy (PTX) 
(22-24). These authors at least implicitly endorse surgery 
for 
conection of these mental changes, even at mild levels of 
hypercalcemia. 
Questions even more fundamental than response to PTX are 
still in need of research: How often do neurobehavioral abnor-
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malities occur in PHPT? What variations occur in tiiese symp-
toms? What is the relationship between these neurobehavioral 
abnormalities and semm calcium? 
In this paper we present our findings on a group of pa-
tients with PHPT in whom neurobehavioral assessment was per-
formed shortly after the diagnosis had been made and again 




Thirty-four patients with no previous history of parathyroid 
disease were evaluated over a 30-month period. These cases, re-
fened for neurobehavioral assessment from the Bone & Mineral 
Division, represented siightiy more than half of the PHPT cases 
seen in the clinic during this period. Not all of the physicians in 
the Bone & Mineral Division were enrolling patients when the 
study began. Any bias introduced into the sample studied was 
due to differences in the practices of the physicians who refened 
patients and those who did not. All patients who were refened to 
the study, 23 women and I I men, were evaluated. Their mean 
age was 52.5 ± 12.3 years (mean ± standard deviation), and on 
the average they had high school educations (12.0 ± 2.7 years). 
Patients were excluded from the study if they had a history of 
substance abuse, secondary hyperparathyroidism, or coinciden-
tal neurological diagnosis. As a group, these patients had mild 
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Table 
Case Series Studies of Psychiatric Symptoms in Hyperparathyroidism 
Number of Neuropsychiatric 
Authors Cases Symptoms, n(%) Types of Symptoms 
Eitinger(1942) (9) .SO 7(14) "Psychic changes" 
St. Goar(1957)(10) 45 3(7) "Pronounced emotional symptoms" 
Cope(1960)(14) 230 2(1) "Mental disturbance" 
Hellstt-om & Ivermark (1962) (11) 138 11 (8) Nervous disorders; depression 
Karpati& Frame (1964) (12) .^ 3 14 (42) Anxiety, tension, irritability, 
depression, confusional state 
Henson(1966)(13) 34 8(24) Depression, anxiety, loss of energy, 
paranoia 
Watson (1968) (15) 200 8 (4) "Mental symptoms"; "psychological 
disorders" 
Anderson* (1968) (16) 30 3 (10) 
7 (23) 
Depression, loss of energy, thought 
disorder, paranoia, disoriented 
Petersen (1968) (17) 54 36 (65) Impairment of memory, neurasthenic 
personality changes, affective dis-
turbance, acute organic psychosis 
with disorientation, delerium, con-
fusion, paranoid ideas 
Mallette etal (1974) (18) 51 19 (33) Decreased memory for recent events, 
irritability, depression, one case 
psychotic, one case delirious 
Palmer (1983) (19) IIO 25 (23) Poor memory, anxiety, depression, 
hysterical personality, organic 
brain syndrome 
Jobom etal (1986) (20) 441 102 (23) Depression, anxiety, psychosis, 
organic brain syndrome, minor 
cerebral impairment 
•Regarding neuropsychiatric symptoms, the first entry is the number of patients who presented as psychotic, and the second 
entry is the number of patients who gave a history of depression and loss of energy. 
PHPT with a mean calcium of 11.5 ± 1.05 mg/dL. Of the entire 
sample, 21% had no physical symptoms directly refenable to 
hyperthyroidism or hypercalcemia; only 10% had renal stones, 
and another 7% had peptic ulcers. The remaining patients had 
incidental medical diseases, of which hypertension was the most 
common. In general, patients with a semm calcium level greater 
than 11.5 mg/dL were refened for elective surgery, but this pro-
cedure was not always followed, and not all patients refened for 
surgery agreed to proceed. 
Procedures 
To evaluate personality functioning and mental status, each 
patient received a battery of neuropsychological tests and/or 
a psychiatric interview; seven had psychological testing alone, 
while three had the interview alone. Differences in how the 
patients were evaluated were due to the temporary unavail-
ability of the neuropsychologist or psychiatrist for inpa-
tients with brief hospitalizations. The brief neuropsychological 
battery assessed amnestic, intellectual, motor, psychomotor, 
and personality functioning. The battery was composed of the 
Similarities, Block Design, and Digit Symbol subtests from the 
Wechsler Adult Intelligence Scale (25), the Trail Making Test 
(26), the Short-Term Memory (STM) Distractor Test (27), 
Halstead's Finger Oscillation Test (28), and the Minnesota Mul-
tiphasic Personality Inventory (MMPI) (29). The mean of the 
three IQ subtests was used in the data analysis. These IQ sub-
tests primarily measure the effects of fluid intelligence, which 
involves intellectual abilities necessary for the rapid solving of 
novel problems. The Trail Making Test is a general indicator of 
cerebral dysfunction, taken from the Halstead-Reitan Neuro-
psychology Battery. Adequate performance on this test pre-
sumes normal visual scanning, concentration, and psychomotor 
speed. The version of the STM Distractor Test that we used re-
quired subjects to remember a word during a 10- or 20-second 
period of subtracting backwards by threes from a three-digit 
number Patients were also tested after a no-delay interval, but 
only the average of the 10- and 20-second conditions was used in 
the data analysis. The STM Distractor Test has been shown to be 
sensitive to memory deficits in patients with classical amnesias 
(eg, bilateral hippocampectomy, or alcoholic Korsakoff am-
nesia) (30). The psychiatric interview included an assessment of 
orientation, immediate memory, verbal reasoning, andcon-
stmctional ability, in addition to an evaluation of thinking style> 
delusions, affect, mood, and hallucinations. The patient's his-




Initial findings—To extend the analysis to patients who had 
either a psychiatric interview or a neuropsychological evalu '^ 
tion, but not both, we examined the degree of concordance be-
tween the two methods for classifying patients into three groups-
1) no behavioral disorders, 2) affective disorders, and 3) neU' 
robehavioral signs of brain dysfunction. Independent judgme"'^  
of each patient's classification revealed an 82% agreement (K " 
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^valuation. We reconciled the few differences between the two 
jjiethods and then classified the remaining cases. 
Only 29% of our sample were clearly normal in their neuro-
behavioral function; 32% had signs of affective disorder, while 
39% had signs of cerebral dysfunction. Included in this lat-
ter group was a small number of patients who displayed paranoid 
features in addition to cognitive abnormalities. Comparisons of 
the semm calcium for the three groups indicated a significant 
difference, F(2,28) = 4.86, P < 0.05. Planned comparisons 
ijidicated that the group judged to be normal had lower mean cal-
cium levels (10.9 ± 0.88 mg/dL) than the other two groups 
combined, t(28) = -2.15, P < 0.05. An additional planned 
comparison indicated that the patients with affective disorders 
had a lower mean calcium (11.25 ± 0.66 mg/dL) than patients 
with signs of brain dysfunction (12.17 ± 1.17 mg/dL), f(28) = 
2.32, P < 0.05. 
These analyses suggest that qualitative differences in neuro-
behavioral dysfunction occuned as a consequence of increas-
ing calcium levels. Subsequent analyses showed that the inten-
sity of neurobehavioral impairment, as measured by tests of 
motor speed, psychomotor speed, intelligence, and short-term 
memory, was also correlated with serum calcium. The cone-
lations were; -0.33, P < 0.05, for the mean tapping score 
averaged over the two hands; - 0.45, P < 0.01, for fluid in-
telligence; -0.36, P < 0.05, for STM; and 0.39, P < 0.05, for 
the Trail Making Test. The direction of all four conelations indi-
cated that poorer performance was associated with higher cal-
cium levels. Only the depression scale of the MMPI failed to 
significantiy conelate with semm calcium. 
Effects of PTX—Nineteen patients had repeat testing of neu-
robehavioral function. Ten patients had testing repeated approx-
imately six months after successful PTX (mean preoperative 
serum calcium was 11.7 ± 1.0 mg/dL, and mean semm calcium 
at follow-up was 9.2 ± 0.94 mg/dL). Repeat testing was per-
formed in the remaining nine patients six months after the initial 
evaluation (mean serum calcium at initial testing was 11.0 ± 
0.98 mg/dL, and mean semm calcium at follow-up was 10.7 ± 
0.82 mg/dL). A significant difference occuned in the amount of 
change in semm calcium between the surgical and nonsurgical 
groups, F(l,16) = 7.63, P < 0.01, with the nonsurgical group 
displaying no significant reduction in serum calcium. While 
PTX lowered semm calcium, nonsurgical treatment did not. 
At the initial evaluation, the surgical and nonsurgical groups 
did not differ regarding age, education, sex, and semm calcium. 
The two groups did not differ on the interval between the two 
evaluations. Despite the significant reduction in the semm cal-
cium following PTX, we observed no differential improvement 
in functioning for those behavioral domains that were conelated 
with the semm calcium at the initial testing. 
Case Reports 
Serum calcium was associated with type and severity of neuro-
hfihavioral dysfunction. However, the modest size of the correlations 
n^ggested that factors other than calcium contributed to a patient's be-
'•avioral condition. The following cases are examples of patients whose 
Psychopathology was long-standing. PTX had little effect on the long-
•^te outcome of their behavioral disorder 
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Casel 
A 49-year-old woman underwent surgery for an adenoma; her cal-
cium level nearest the interview was 11.4 mg/dL. Her history suggested 
several episodes of fatigue and depression throughout her adult life. She 
had attempted suicide by overdose nine years before surgery. Pre-
operative mental status examination revealed a compulsive personality 
style and euthymic mood. Chart review revealed documentation of "se-
vere anxiety" three years after surgery, and psychiatric treatment was 
advised. 
Case 2 
A 60-year-old woman worried about "becoming crazy" after sur-
gery. The calcium level near her interview was 11.2 mg/dL. Biopsy 
diagnosed adenomata of two glands, with hyperplasia of the biopsied 
remaining two glands; postoperative calcium level was normal. She 
described lifelong anxiety, and the mental status examination revealed 
mild dysphoria, a compulsive behavioral style, and mild anxiety. The 
patient subsequentiy suffered three episodes of major depressive dis-
order beginning one year after surgery. Treatment with tricyclic anti-
depressants was successful, and she retumed to a euthymic state. 
Case 3 
A 73-year-old woman had moderate anxiety in her preoperative 
interview. Her calcium level near the interview was 10.9 mg/dL. An 
adenoma was removed during surgery, but 16 months later chart notes 
revealed that the patient experienced continued fatigue with normal 
calcium levels. 
Case 4 
The examination of a 59-year-old woman revealed paranoia, intellec-
tual deficits, and forgetfulness. Her calcium level near the interview 
was 12.5 mg/dL, and an adenoma was removed at surgery. Chart review 
revealed a schizophreniform psychosis six months postsurgery with 
psychiatric hospitalization. A 14-year presurgical history of recurrent 
psychosis was discovered. 
Discussion 
As indicated in the Table, several studies address the problem 
of neurobehavioral symptoms in PHPT. Most of these studies 
were based on retrospective chart review, and details of the 
method of evaluation were scant in several reports. These case-
series studies also varied on the amount of detail provided about 
types of psychiatric symptoms. Several investigators employed 
vague and general terms when describing their patients. This 
vagueness not only reduces the relevance of these studies for cur-
rent practice, but also raises questions about the sensitivity of 
these investigations to the presence of subtie or atypical be-
havioral disorders. As the Table indicates, those investigators 
who distinguished among various types of psychiatric symp-
toms uniformly reported higher rates than those who used global 
terms such as "emotional symptoms" or "emotional distur-
bance." Many of the earlier studies in particular are flawed by 
overiy diffuse analyses of psychiatric symptomatology, which 
would bias them toward overiy conservative estimates of rates of 
psychopathology. 
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In outpatient medical settings psychiatric illness prevalence 
ranges from 10% to 20% (31). The prevalence of psychological 
morbidity in this study is at least 3.5 times higher than expected. 
Even when allowing for different methods of investigation 
among studies, the literature indicates that psychiatric morbidity 
is considerably higher in PHPT than would be expected among 
general medical outpatients. 
The types of neurobehavioral symptoms found in this study 
were similar to those reported by other investigators. We found 
mild to severe affective disorder, paranoid ideation, anxiety, 
lethargy, impaired motor and psychomotor speed, disorienta-
tion, impairment of memory, impaired fluid intelligence, and 
constmctional dyspraxia for both drawings and block constmc-
tions. The range of neurobehavioral syndromes seen in PHPT is 
fairly well established and includes affective disorder, psychotic 
symptoms, particularly paranoid ideation, and mild to severe 
organic brain syndrome. 
Semm calcium conelated with both the type and severity of 
the neurobehavioral abnormalities observed. Affective disor-
ders seemed to lie midway between normal functioning and 
impairment of cognitive functioning, while a few of the pa-
tients who displayed signs of cognitive deficits also had para-
noid delusions. Further, semm calcium formed small but signifi-
cant conelations with measures of motor and psychomotor 
speed, memory functioning, and fluid intelligence. Based on his 
review of earlier cases and on his own work, Peterson (17) sug-
gested that hypercalcemia between 12 and 16 mg/dL was associ-
ated with personality changes, while organic psychosis and con-
fusional states occuned when hypercalcemia was between 16 
and 19 mg/dL. Above 19 mg/dL, somnolence and coma occur 
Our results and those of others, including Peterson's, suggest 
that this scheme is oversimplified. Personality changes can oc-
cur below the 12 mg/dL range, while signs of organic psychosis 
can appear at the 12 to 16 mg/dL range. Further, elevations above 
20 mg/dL do not lead to coma and somnolence in an obligatory 
manner Hanes (32) and Frame et al (33) reported on patients 
who were "cheerful and uncomplaining" despite a semm cal-
cium level of 20 mg/dL. A weak, general relationship exists 
between hypercalcemia and the type and intensity of neuro-
behavioral dysfunction. However, individual differences play a 
major role in moderating this relationship. 
Although patients with signs of affective disorder tended 
to have calcium elevations midway between those of the non-
involved patients and those with cognitive changes, some ele-
ments of depression in these cases were independent of calcium 
levels. This independence surfaced in the failure to find a cor-
relation between the depression scale on the MMPI and the ini-
tial calcium levels. Further, chart reviews indicated that some 
patients with signs of affective disorder were depressed prior 
to the diagnosis of PHPT and that several of these patients 
continued to be depressed following conection of the hyper-
calcemia. 
Depression was related to cognitive impairment, suggesting 
that depression and hypercalcemia might make somewhat inde-
pendent contributions to the prediction of cognitive deficits in 
patients with PHPT. When findings from the depression scale of 
the MMPI were combined with presurgical semm calcium, the 
multiple conelation of this pair of variables with our remaining 
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neurobehavioral tests improved considerably over the conela-
tion with calcium alone. This finding was particularly strong for 
tests of memory and psychomotor speed. The multiple conela-
tion between calcium and depression, on the one hand, and the 
Trail Making Test, on the other hand, was 0.52. The multiple 
conelation with performance on the STM Distractor Test was 
0.65. 
As noted, in some patients emotional symptoms long predated 
PHPT, raising the possibility that emotional disorder might contrib-
ute to the risk of developing PHPT. However, several studies failed 
to find an increased incidence of PHPT in psychiatric populations 
(34,35). SmaU increases ui calcium have been observed to occur in 
the "switch" phenomena from depression to mania (36,37). Also, 
lithium carbwnate-induced hyjjerparathyroidism has been reported 
(38), indicating that some treatments of emotional disorders can in-
crease the risk of PHPT. 
Fluctuations in semm calcium are associated with behavioral 
changes in a variety of diseases, suggesting an important role for 
calcium in modulating behavior (39-41). Changes in calcium 
could influence behavior through a large number of biochemical 
pathways. Calcium is essential for the release of neurotrans-
mitters and hormones. Consequently, calcium can have direct 
and indirect effects on neuronal functioning. The neuronal 
effects of calcium, occurring through hormonal release, are par-
ticularly varied. Over 30 neuropeptides, some with hormone-
like stmcture, are known to act as neurotransmitters (42). Re-
ceptors for 1,25-dihydroxy vitamin Dj are thought to be present 
in rat brain (43). The discovery of endorphins and other endoge-
nous opiates has led to speculation about their possible role in 
psychopathology (42). |3-endorphins might play a role in cal-
cium flux and neurotransmitter release (44). 
Surgery did not lead to differential improvement in cognitive 
functioning. Our results agree with the negative findings of 
Cogan's group (45). Numann and colleagues (46) did find some 
improvement in memory and verbal reasoning following sur-
gery. Although many of the neurobehavioral tests that we used 
were also included in the Numann study, we used a different 
approach to assess verbal memory (STM Distractor Test versus 
Wechsler Memory Scale). This difference in method could be 
the basis of the different results of the two studies. However, 
Cogan's group, like Numann et al, used the Wechsler Mem-
ory Scale to assess memory and failed to find any significant 
postoperative improvement in seven patients with PHPT 
Numann and colleagues reported improvement on the Sim-
ilarities subtest of the Wechsler Adult Intelligence Scale, and 
the absence of such improvement in the present study is even 
more difficult to understand. The failure to replicate Cogan et 
al's findings cautions against using them to build a rationale for 
performing PTX as a treatment of neurobehavioral symptoms in 
mild PHPT. Treatment studies involving larger samples are 
needed to determine which of the results previously mentioned 
are most reliably replicated. PTX has not consistently led to ii" ' 
provement in behavioral functioning among patients with m'''' 
PHPT. However, there may be subgroups of patients whose n^f' 
robehavioral symptoms could be ameliorated by PTX. Jobom 
and colleagues (47) reported improvement in the cognitive i t i^ 
tioning of eight elderly patients with an early onset of pf^ 
gressive dementia following PTX for treatment of their PH? ' 
Hypercalcemia and Behavioral Disorders—BroWi^ ^ 
future research of the neurobehavioral effects of PTX should in-
clude methodologies for identifying particularly responsive 
subgroups. 
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